In SLE, TGP exerts its immunomodulatory effects primarily by inhibiting the overexpression of inflammatory cytokines such as TNF-α, IL-1β, and IL-6, while regulating immune cell activity. This evidence concerns the gene TGM4 and systemic lupus erythematosus.